The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Trends in 2009: Facing the Challenges of Introducing Biosimilars or Follow-on Biologics in the North American Market

The so-called biotechnology drugs or biologics (large, complex protein molecules derived from living cells, usually by use of recombinant DNA technology) are among the fastest-growing class of pharmaceuticals. Within the next two years, some market forecasts predict that biopharmaceuticals will amount to more than 50% of newly approved medicines. In addition to a growing market share, [...]

Introducing…

Beni Rovinski of Lumira Capital joined the blog today.  Beni is a Managing Director focused on US and Canadian mid- to late-stage private and public companies involved in drug discovery and development, biological and small molecule therapeutics, drug delivery and specialty pharmaceuticals.  Take a look at his full bio here.

Follow

Get every new post delivered to your Inbox.

Join 82 other followers